Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | CHEK2 |
| Variant | L216* |
| Impact List | nonsense |
| Protein Effect | loss of function - predicted |
| Gene Variant Descriptions | CHEK2 L216* results in a premature truncation of the Chek2 protein at amino acid 216 of 543 (UniProt.org). L216* has not been characterized, however, due to the effects of other truncations downstream of L216 resulting in disruption of the protein kinase domain (PMID: 11053450, PMID: 16982735, PMID: 31050813), is predicted to lead to a loss of Chek2 protein function. |
| Associated Drug Resistance | |
| Category Variants Paths |
CHEK2 mutant CHEK2 inact mut CHEK2 L216* |
| Transcript | NM_007194.4 |
| gDNA | chr22:g.28719431A>T |
| cDNA | c.647T>A |
| Protein | p.L216* |
| Source Database | RefSeq |
| Genome Build | GRCh38/hg38 |
| Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
|---|---|---|---|---|---|
| NM_145862.2 | chr22:g.28719431A>T | c.647T>A | p.L216* | RefSeq | GRCh38/hg38 |
| NM_007194.3 | chr22:g.28719431A>T | c.647T>A | p.L216* | RefSeq | GRCh38/hg38 |
| NM_007194.4 | chr22:g.28719431A>T | c.647T>A | p.L216* | RefSeq | GRCh38/hg38 |
| NM_145862.2 | chr22:g.28719431A>T | c.647T>A | p.L216* | RefSeq | GRCh38/hg38 |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|